The latest announcement is out from HYTN Innovations Inc ( (TSE:HYTN) ).
HYTN Innovations Inc. has announced a collaboration with SNDL Inc. to develop Good Manufacturing Practices (GMP) compliant vape cartridges for global markets. This partnership capitalizes on HYTN’s GMP-certified facility and quality systems expertise while utilizing SNDL’s equipment, consumables, and capital to meet regulatory requirements. The collaboration aligns with the increasing demand for GMP-compliant cannabis vape products, especially in markets like the UK and Germany, highlighting HYTN’s strategic focus on international distribution.
More about HYTN Innovations Inc
HYTN Innovations Inc. is a pharmaceutical company that formulates, manufactures, markets, and sells products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids and psilocybe-derived tryptamines. The company aims to become a leading provider in this sector.
YTD Price Performance: 55.56%
Average Trading Volume: 91,060
Technical Sentiment Consensus Rating: Sell
Current Market Cap: C$36.44M
Find detailed analytics on HYTN stock on TipRanks’ Stock Analysis page.